Rhythm Pharmaceuticals (RYTM) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.
- Rhythm Pharmaceuticals' Other Gross PP&E Adjustments fell 14.98% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 14.98%. This contributed to the annual value of -$2.4 million for FY2024, which is 40000.0% down from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Other Gross PP&E Adjustments of -$9.4 million as of Q3 2025, which was down 14.98% from -$8.1 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $1.4 million during Q4 2021, and its lowest value of -$9.4 million during Q3 2025.
- For the 5-year period, Rhythm Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$4.9 million, with its median value being -$4.5 million (2023).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 33674.7% in 2023, then crashed by 40000.0% in 2024.
- Rhythm Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $1.4 million in 2021, then plummeted by 123.95% to -$332000.0 in 2022, then skyrocketed by 336.75% to $786000.0 in 2023, then plummeted by 400.0% to -$2.4 million in 2024, then plummeted by 297.03% to -$9.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$9.4 million for Q3 2025, versus -$8.1 million for Q2 2025 and -$8.1 million for Q1 2025.